Skip to main content

Sanofi Ventures — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

69
Companies
$4.2B
Total invested
$61.3M
Avg. check
19
Industries
Biotechnology 14Health Care 14Medical 10Therapeutics 7Pharmaceutical 7Life Science 5+13 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–69 of 69
Nura Bio
September 2024

Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.

Biotechnology · South San Francisco$68.0M Series A
Atropos Health
May 2024

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Clinical Trials · New York$33.0M Series B
Nucleai
April 2024

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

Artificial Intelligence (AI) · Chicago$14.0M Series Unknown
NextPoint Therapeutics
February 2024

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Biotechnology · Cambridge$42.5M Series B
Sudo Biosciences
February 2024

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Biopharma · Carmel$30.0M Series B
ROME Therapeutics
September 2023

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Biotechnology · Cambridge$72.0M Series B
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Inozyme
July 2023

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Biotechnology · Boston$60.0M Post Ipo Equity
Veralox Therapeutics
June 2023

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

Biotechnology · Frederick$24.0M Series Unknown
OMass Therapeutics
May 2023

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Life Science · Oxford$12.5M Series B
QurAlis
March 2023

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Biotechnology · Cambridge$88.0M Series B
Avilar Therapeutics
February 2023

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

Biotechnology · Waltham$15.0M Seed
Matchpoint Therapeutics
October 2022

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Biotechnology · Cambridge$70.0M Series A
Empatica
August 2022

Empatica is an affective computing company focused on human data analytics.

Artificial Intelligence (AI) · Cambridge$25.9M Series B
Common Sensing
January 2021

Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.

Health Care · CambridgePrivate Equity
Lava Therapeutics
September 2020

Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.

Biotechnology · Utrecht$83.0M Series C
NodThera
June 2020

NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.

Biotechnology · Little Chesterford$55.0M Series B
Curisium
December 2017

Innovative Healthcare Contracting

Blockchain · Manhattan Beach$3.5M Seed
NeuroVia
July 2017

NeuroVia is a biopharmaceutical company.

Biopharma · San Francisco$14.0M Series A
Lysosomal Therapeutics
February 2015

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

Biotechnology · Cambridge$20.0M Series A
Lumena Pharmaceuticals
March 2014

Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.

Biotechnology · San Diego$45.0M Series B

Where Sanofi Ventures invests

Biotechnology14
Health Care14
Medical10
Therapeutics7
Pharmaceutical7
Life Science5

About Sanofi Ventures's portfolio

How many companies has Sanofi Ventures invested in?▸

Sanofi Ventures has invested in 69 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Sanofi Ventures invest in?▸

Sanofi Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 19 different industry categories.

What is Sanofi Ventures's largest investment?▸

Among tracked funding rounds, QurAlis received $88.0M in a Series B round. Sanofi Ventures's total known invested capital is $4.2B.

What is the average investment size for Sanofi Ventures?▸

Sanofi Ventures's average investment size is $61.3M across its portfolio of 69 companies.

What are Sanofi Ventures's most recent investments?▸

Recent Sanofi Ventures portfolio additions include Nura Bio, Atropos Health, Nucleai, NextPoint Therapeutics, Sudo Biosciences. These companies were founded in 2020 or later.

Reach the founders behind these 69 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →